Organicell appoints Matt Sinnreich as COO and acting CEO; founder Mitrani shifts to EVP of Sales

Zeo ScientifiX, Inc.

Albert Mitrani stepped down as CEO on July 21, 2022, appointed EVP of Sales.
Matt Sinnreich appointed COO and acting CEO; he is an early-stage investor in Organicell.
Sinnreich receives immediate grant of 10M restricted shares and warrants for 40M shares at $0.034.
First-year compensation: 24M shares vesting monthly; second-year base salary $25k/month.
Milestone bonuses: up to 15M shares upon achieving market caps of $1B, $2B, $5B, or $10B.

item 3.02 item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Role change

Albert Mitrani

Executive Vice President of Sales

ZEOX · Zeo ScientifiX, Inc.

Effective: 2022-07-21
Successor: Matthew Sinnreich
Filed: July 26, 2022, 7:59 PM ET

Effective July 21, 2022 (the “ Effective Date ”), Albert Mitrani stepped down as the Company’s Chief Executive Officer and was appointed by the Board of Directors to the position of Executive Vice President of Sales.

Appointed (interim)

Matthew Sinnreich

Chief Operating Officer and Acting Chief Executive Officer

ZEOX · Zeo ScientifiX, Inc.

Effective: 2022-07-21
Filed: July 26, 2022, 7:59 PM ET

On the Effective Date, Matthew Sinnreich was appointed by the Board of Directors to the position of Chief Operating Officer and Acting Chief Executive Officer.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Albert Mitrani was appointed as Executive Vice President of Sales at Zeo ScientifiX, Inc..

Action: stepped down as Chief Executive Officer and appointed Executive Vice President of Sales
Role: Executive Vice President of Sales

Exact text from the filing

Effective July 21, 2022 (the “ Effective Date ”), Albert Mitrani stepped down as the Company’s Chief Executive Officer and was appointed by the Board of Directors to the position of Executive Vice President of Sales.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Matthew Sinnreich was appointed as Chief Operating Officer and Acting Chief Executive Officer at Zeo ScientifiX, Inc..

Action: appointed
Role: Chief Operating Officer and Acting Chief Executive Officer

Exact text from the filing

On the Effective Date, Matthew Sinnreich was appointed by the Board of Directors to the position of Chief Operating Officer and Acting Chief Executive Officer.

View on SEC.gov

Zeo ScientifiX, Inc. filing history →

Source: SEC EDGAR

accession 0001829126-22-014634

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.